nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Zalcitabine—Gemcitabine—breast cancer	0.377	1	CrCrCtD
Didanosine—SLC29A2—Gemcitabine—breast cancer	0.184	0.474	CbGbCtD
Didanosine—SLC29A1—Gemcitabine—breast cancer	0.106	0.272	CbGbCtD
Didanosine—SLC29A1—Fluorouracil—breast cancer	0.0904	0.233	CbGbCtD
Didanosine—SLC29A2—Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane—SLC28A1—breast cancer	0.0103	0.136	CbGpPWpGaD
Didanosine—SLC22A6—Methotrexate—breast cancer	0.00796	0.0205	CbGbCtD
Didanosine—SLC29A1—Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane—SLC28A1—breast cancer	0.00712	0.0945	CbGpPWpGaD
Didanosine—PNP—Purine salvage—APRT—breast cancer	0.00532	0.0707	CbGpPWpGaD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—SLC28A1—breast cancer	0.00265	0.0352	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—APRT—breast cancer	0.00253	0.0335	CbGpPWpGaD
Didanosine—PNP—uterus—breast cancer	0.00222	0.0826	CbGeAlD
Didanosine—PNP—Purine metabolism—ADSL—breast cancer	0.00206	0.0273	CbGpPWpGaD
Didanosine—PNP—Purine catabolism—GPX1—breast cancer	0.002	0.0266	CbGpPWpGaD
Didanosine—PNP—female reproductive system—breast cancer	0.00199	0.0742	CbGeAlD
Didanosine—PNP—bone marrow—breast cancer	0.00188	0.0701	CbGeAlD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—SLC28A1—breast cancer	0.00184	0.0244	CbGpPWpGaD
Didanosine—PNP—female gonad—breast cancer	0.00181	0.0676	CbGeAlD
Didanosine—SLC29A1—mammary gland—breast cancer	0.00179	0.0668	CbGeAlD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—SLCO1B1—breast cancer	0.00177	0.0235	CbGpPWpGaD
Didanosine—PNP—endocrine gland—breast cancer	0.00169	0.0628	CbGeAlD
Didanosine—SLC29A2—adipose tissue—breast cancer	0.00163	0.0607	CbGeAlD
Didanosine—SLC29A2—female reproductive system—breast cancer	0.0015	0.0558	CbGeAlD
Didanosine—SLC29A1—nipple—breast cancer	0.00148	0.0553	CbGeAlD
Didanosine—SLC29A2—adrenal gland—breast cancer	0.00146	0.0544	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—CDA—breast cancer	0.00143	0.019	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—CDA—breast cancer	0.00137	0.0181	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—APRT—breast cancer	0.00127	0.0169	CbGpPWpGaD
Didanosine—SLC29A2—endocrine gland—breast cancer	0.00127	0.0472	CbGeAlD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—SLCO1B1—breast cancer	0.00123	0.0163	CbGpPWpGaD
Didanosine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.0012	0.016	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—XRCC3—breast cancer	0.00113	0.015	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—UMPS—breast cancer	0.00108	0.0144	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—UMPS—breast cancer	0.00104	0.0137	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—NME1—breast cancer	0.00104	0.0137	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—ADSL—breast cancer	0.00104	0.0137	CbGpPWpGaD
Didanosine—PNP—Gefitinib—Lapatinib—breast cancer	0.00101	0.313	CbGdCrCtD
Didanosine—SLC29A1—endometrium—breast cancer	0.000896	0.0334	CbGeAlD
Didanosine—SLC29A2—lymph node—breast cancer	0.000876	0.0326	CbGeAlD
Didanosine—SLC29A1—uterus—breast cancer	0.000826	0.0308	CbGeAlD
Didanosine—SLC29A1—pituitary gland—breast cancer	0.000811	0.0302	CbGeAlD
Didanosine—SLC29A1—adipose tissue—breast cancer	0.000807	0.0301	CbGeAlD
Didanosine—PNP—Purine metabolism—GPX1—breast cancer	0.00077	0.0102	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—DPYD—breast cancer	0.00075	0.00996	CbGpPWpGaD
Didanosine—SLC29A1—female reproductive system—breast cancer	0.000742	0.0276	CbGeAlD
Didanosine—SLC29A1—adrenal gland—breast cancer	0.000724	0.027	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—DPYD—breast cancer	0.000718	0.00952	CbGpPWpGaD
Didanosine—SLC29A1—bone marrow—breast cancer	0.000701	0.0261	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ABCG2—breast cancer	0.000697	0.00926	CbGpPWpGaD
Didanosine—SLC29A1—female gonad—breast cancer	0.000675	0.0252	CbGeAlD
Didanosine—SLC29A1—endocrine gland—breast cancer	0.000628	0.0234	CbGeAlD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00057	0.00757	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—SMUG1—breast cancer	0.000534	0.00709	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000521	0.00692	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000521	0.00692	CbGpPWpGaD
Didanosine—PNP—Paclitaxel—Docetaxel—breast cancer	0.000512	0.16	CbGdCrCtD
Didanosine—SLC29A1—lymph node—breast cancer	0.000434	0.0162	CbGeAlD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000432	0.00573	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TYMS—breast cancer	0.000427	0.00567	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TYMS—breast cancer	0.000409	0.00543	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ERCC2—breast cancer	0.000397	0.00527	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000395	0.00524	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000395	0.00524	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—GPX1—breast cancer	0.000387	0.00514	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.00038	0.00505	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.00038	0.00505	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Idarubicin—breast cancer	0.000374	0.116	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—breast cancer	0.000373	0.00496	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000361	0.0048	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000361	0.0048	CbGpPWpGaD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—breast cancer	0.000351	0.00466	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000327	0.00435	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.000318	0.00422	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000299	0.00397	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.00029	0.00384	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000274	0.00364	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000265	0.00352	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000265	0.00352	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000264	0.0035	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000264	0.0035	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.000263	0.0035	CbGpPWpGaD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—breast cancer	0.000243	0.00323	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.000241	0.0032	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000232	0.00308	CbGpPWpGaD
Didanosine—PNP—Tamoxifen—Toremifene—breast cancer	0.00023	0.0715	CbGdCrCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.000227	0.00301	CbGpPWpGaD
Didanosine—PNP—Clobetasol propionate—Fluoxymesterone—breast cancer	0.000227	0.0706	CbGdCrCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—COX11—breast cancer	0.00022	0.00291	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.00022	0.00291	CbGpPWpGaD
Didanosine—PNP—Testosterone Propionate—Fluoxymesterone—breast cancer	0.000206	0.0642	CbGdCrCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000201	0.00267	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000201	0.00267	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.0002	0.00265	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000197	0.00261	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000193	0.00257	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000193	0.00257	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000184	0.00244	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000184	0.00244	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Epirubicin—breast cancer	0.000172	0.0534	CbGdCrCtD
Didanosine—PNP—Danazol—Fluoxymesterone—breast cancer	0.000171	0.0534	CbGdCrCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000166	0.00221	CbGpPWpGaD
Didanosine—PNP—Metabolism—SYNJ2—breast cancer	0.000164	0.00217	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—breast cancer	0.000159	0.0494	CbGdCrCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000158	0.0021	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000158	0.0021	CbGpPWpGaD
Didanosine—PNP—Norethindrone—Fluoxymesterone—breast cancer	0.000154	0.0481	CbGdCrCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000153	0.00202	CbGpPWpGaD
Didanosine—PNP—Metabolism—NDUFS3—breast cancer	0.000152	0.00202	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000152	0.00202	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000152	0.00202	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000152	0.00202	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000144	0.00192	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000144	0.00192	CbGpPWpGaD
Didanosine—PNP—Metabolism—CHST9—breast cancer	0.000143	0.0019	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—breast cancer	0.000142	0.00188	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000141	0.00188	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000139	0.00185	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000137	0.00181	CbGpPWpGaD
Didanosine—PNP—Metabolism—COX11—breast cancer	0.000136	0.0018	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000134	0.00178	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000134	0.00178	CbGpPWpGaD
Didanosine—PNP—Metabolism—SHMT1—breast cancer	0.000124	0.00165	CbGpPWpGaD
Didanosine—PNP—Metabolism—CDA—breast cancer	0.000124	0.00165	CbGpPWpGaD
Didanosine—Zalcitabine—CYP2D6—breast cancer	0.00012	0.538	CrCbGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TUBB3—breast cancer	0.00012	0.0016	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.00012	0.00159	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.00012	0.00159	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLCO1B1—breast cancer	0.000119	0.00159	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC2A5—breast cancer	0.000119	0.00159	CbGpPWpGaD
Didanosine—PNP—Metabolism—APRT—breast cancer	0.000115	0.00153	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000115	0.00153	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000109	0.00145	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000109	0.00145	CbGpPWpGaD
Didanosine—PNP—Metabolism—ANGPTL4—breast cancer	0.000108	0.00144	CbGpPWpGaD
Didanosine—PNP—Metabolism—ESRRA—breast cancer	0.000108	0.00144	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000106	0.0014	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000105	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000105	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000105	0.0014	CbGpPWpGaD
Didanosine—Zalcitabine—CYP3A4—breast cancer	0.000103	0.462	CrCbGaD
Didanosine—PNP—Metabolism—HADHB—breast cancer	0.000103	0.00136	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPI—breast cancer	0.000103	0.00136	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.0001	0.00133	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALDH1A1—breast cancer	9.81e-05	0.0013	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALDH7A1—breast cancer	9.81e-05	0.0013	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCC1—breast cancer	9.81e-05	0.0013	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCG2—breast cancer	9.81e-05	0.0013	CbGpPWpGaD
Didanosine—PNP—Metabolism—PHGDH—breast cancer	9.4e-05	0.00125	CbGpPWpGaD
Didanosine—PNP—Metabolism—UMPS—breast cancer	9.4e-05	0.00125	CbGpPWpGaD
Didanosine—PNP—Metabolism—FHL2—breast cancer	9.4e-05	0.00125	CbGpPWpGaD
Didanosine—PNP—Metabolism—NME1—breast cancer	9.4e-05	0.00125	CbGpPWpGaD
Didanosine—PNP—Metabolism—ADSL—breast cancer	9.4e-05	0.00125	CbGpPWpGaD
Didanosine—PNP—Metabolism—BRIP1—breast cancer	9.22e-05	0.00122	CbGpPWpGaD
Didanosine—PNP—Metabolism—HPSE—breast cancer	9.22e-05	0.00122	CbGpPWpGaD
Didanosine—PNP—Metabolism—LDHB—breast cancer	9.22e-05	0.00122	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	9.07e-05	0.0012	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA3—breast cancer	8.74e-05	0.00116	CbGpPWpGaD
Didanosine—PNP—Metabolism—HMMR—breast cancer	8.74e-05	0.00116	CbGpPWpGaD
Didanosine—PNP—Metabolism—ABCC1—breast cancer	8.74e-05	0.00116	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TFRC—breast cancer	8.74e-05	0.00116	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPARGC1B—breast cancer	8.47e-05	0.00112	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NCOA2—breast cancer	8.41e-05	0.00112	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TUBB3—breast cancer	8.34e-05	0.00111	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	8.03e-05	0.00107	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A5—breast cancer	8.03e-05	0.00107	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA4—breast cancer	8e-05	0.00106	CbGpPWpGaD
Didanosine—PNP—Metabolism—CA9—breast cancer	8e-05	0.00106	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA2—breast cancer	7.79e-05	0.00103	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPX2—breast cancer	7.79e-05	0.00103	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A1—breast cancer	7.75e-05	0.00103	CbGpPWpGaD
Didanosine—PNP—Metabolism—SULT1A1—breast cancer	7.7e-05	0.00102	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPX4—breast cancer	7.7e-05	0.00102	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—ALB—breast cancer	7.53e-05	0.001	CbGpPWpGaD
Didanosine—PNP—Metabolism—IDH1—breast cancer	7.52e-05	0.000998	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTA1—breast cancer	7.52e-05	0.000998	CbGpPWpGaD
Didanosine—PNP—Metabolism—NAT2—breast cancer	7.43e-05	0.000987	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	7.34e-05	0.000974	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	7.34e-05	0.000974	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NCOA1—breast cancer	7.09e-05	0.000941	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	6.94e-05	0.000921	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PLG—breast cancer	6.91e-05	0.000917	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCG2—breast cancer	6.8e-05	0.000902	CbGpPWpGaD
Didanosine—PNP—Metabolism—MED12—breast cancer	6.52e-05	0.000865	CbGpPWpGaD
Didanosine—PNP—Metabolism—DPYD—breast cancer	6.52e-05	0.000865	CbGpPWpGaD
Didanosine—Decreased appetite—Gemcitabine—breast cancer	6.42e-05	0.000495	CcSEcCtD
Didanosine—PNP—Metabolism—ALDOA—breast cancer	6.42e-05	0.000852	CbGpPWpGaD
Didanosine—Chills—Capecitabine—breast cancer	6.41e-05	0.000494	CcSEcCtD
Didanosine—Dyspepsia—Fluorouracil—breast cancer	6.39e-05	0.000493	CcSEcCtD
Didanosine—Nausea—Tamoxifen—breast cancer	6.39e-05	0.000492	CcSEcCtD
Didanosine—Discomfort—Paclitaxel—breast cancer	6.38e-05	0.000491	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—HMOX1—breast cancer	6.38e-05	0.000846	CbGpPWpGaD
Didanosine—Pain—Gemcitabine—breast cancer	6.32e-05	0.000487	CcSEcCtD
Didanosine—Decreased appetite—Fluorouracil—breast cancer	6.32e-05	0.000487	CcSEcCtD
Didanosine—Alopecia—Capecitabine—breast cancer	6.31e-05	0.000487	CcSEcCtD
Didanosine—Dry mouth—Paclitaxel—breast cancer	6.31e-05	0.000486	CcSEcCtD
Didanosine—Asthenia—Thiotepa—breast cancer	6.3e-05	0.000486	CcSEcCtD
Didanosine—Diarrhoea—Vinorelbine—breast cancer	6.29e-05	0.000485	CcSEcCtD
Didanosine—Nausea—Melphalan—breast cancer	6.25e-05	0.000482	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA3—breast cancer	6.23e-05	0.000827	CbGpPWpGaD
Didanosine—Pruritus—Thiotepa—breast cancer	6.21e-05	0.000479	CcSEcCtD
Didanosine—Pain—Fluorouracil—breast cancer	6.21e-05	0.000479	CcSEcCtD
Didanosine—Gastrointestinal pain—Mitoxantrone—breast cancer	6.2e-05	0.000478	CcSEcCtD
Didanosine—Gastrointestinal pain—Irinotecan—breast cancer	6.2e-05	0.000478	CcSEcCtD
Didanosine—Anaphylactic shock—Paclitaxel—breast cancer	6.19e-05	0.000477	CcSEcCtD
Didanosine—PNP—Metabolism—SLC2A2—breast cancer	6.19e-05	0.000821	CbGpPWpGaD
Didanosine—Infection—Paclitaxel—breast cancer	6.15e-05	0.000474	CcSEcCtD
Didanosine—Flatulence—Capecitabine—breast cancer	6.13e-05	0.000472	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCB1—breast cancer	6.12e-05	0.000812	CbGpPWpGaD
Didanosine—Nausea—Goserelin—breast cancer	6.1e-05	0.00047	CcSEcCtD
Didanosine—Pancreatitis—Epirubicin—breast cancer	6.1e-05	0.00047	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	6.08e-05	0.000807	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	6.08e-05	0.000807	CbGpPWpGaD
Didanosine—Abdominal pain upper—Doxorubicin—breast cancer	6.08e-05	0.000469	CcSEcCtD
Didanosine—PNP—Metabolism—ABCG2—breast cancer	6.06e-05	0.000804	CbGpPWpGaD
Didanosine—PNP—Metabolism—CPT1A—breast cancer	6.06e-05	0.000804	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTR—breast cancer	6.06e-05	0.000804	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TFRC—breast cancer	6.06e-05	0.000804	CbGpPWpGaD
Didanosine—Thrombocytopenia—Paclitaxel—breast cancer	6.06e-05	0.000467	CcSEcCtD
Didanosine—Diarrhoea—Thiotepa—breast cancer	6.01e-05	0.000463	CcSEcCtD
Didanosine—Abdominal pain—Mitoxantrone—breast cancer	6e-05	0.000462	CcSEcCtD
Didanosine—Body temperature increased—Irinotecan—breast cancer	6e-05	0.000462	CcSEcCtD
Didanosine—Body temperature increased—Mitoxantrone—breast cancer	6e-05	0.000462	CcSEcCtD
Didanosine—Abdominal pain—Irinotecan—breast cancer	6e-05	0.000462	CcSEcCtD
Didanosine—PNP—Metabolism—HPGDS—breast cancer	5.94e-05	0.000789	CbGpPWpGaD
Didanosine—Anaemia—Docetaxel—breast cancer	5.94e-05	0.000458	CcSEcCtD
Didanosine—PNP—Metabolism—HBA1—breast cancer	5.91e-05	0.000784	CbGpPWpGaD
Didanosine—Anorexia—Paclitaxel—breast cancer	5.9e-05	0.000455	CcSEcCtD
Didanosine—Vomiting—Vinorelbine—breast cancer	5.85e-05	0.000451	CcSEcCtD
Didanosine—Body temperature increased—Gemcitabine—breast cancer	5.84e-05	0.00045	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NCOA2—breast cancer	5.83e-05	0.000774	CbGpPWpGaD
Didanosine—Rash—Vinorelbine—breast cancer	5.8e-05	0.000447	CcSEcCtD
Didanosine—Dermatitis—Vinorelbine—breast cancer	5.79e-05	0.000447	CcSEcCtD
Didanosine—PNP—Metabolism—ACHE—breast cancer	5.76e-05	0.000765	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTT1—breast cancer	5.76e-05	0.000765	CbGpPWpGaD
Didanosine—Headache—Vinorelbine—breast cancer	5.76e-05	0.000444	CcSEcCtD
Didanosine—Leukopenia—Docetaxel—breast cancer	5.75e-05	0.000443	CcSEcCtD
Didanosine—Anaemia—Capecitabine—breast cancer	5.75e-05	0.000443	CcSEcCtD
Didanosine—Body temperature increased—Fluorouracil—breast cancer	5.74e-05	0.000443	CcSEcCtD
Didanosine—Pancreatitis—Doxorubicin—breast cancer	5.64e-05	0.000435	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Paclitaxel—breast cancer	5.64e-05	0.000434	CcSEcCtD
Didanosine—Hyperglycaemia—Epirubicin—breast cancer	5.61e-05	0.000432	CcSEcCtD
Didanosine—Malaise—Capecitabine—breast cancer	5.61e-05	0.000432	CcSEcCtD
Didanosine—Hepatobiliary disease—Methotrexate—breast cancer	5.6e-05	0.000432	CcSEcCtD
Didanosine—Hypersensitivity—Irinotecan—breast cancer	5.59e-05	0.000431	CcSEcCtD
Didanosine—Hypersensitivity—Mitoxantrone—breast cancer	5.59e-05	0.000431	CcSEcCtD
Didanosine—Vomiting—Thiotepa—breast cancer	5.58e-05	0.00043	CcSEcCtD
Didanosine—Leukopenia—Capecitabine—breast cancer	5.57e-05	0.000429	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	5.56e-05	0.000738	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	5.56e-05	0.000738	CbGpPWpGaD
Didanosine—Paraesthesia—Paclitaxel—breast cancer	5.55e-05	0.000428	CcSEcCtD
Didanosine—Rash—Thiotepa—breast cancer	5.54e-05	0.000427	CcSEcCtD
Didanosine—Dermatitis—Thiotepa—breast cancer	5.53e-05	0.000427	CcSEcCtD
Didanosine—Agranulocytosis—Methotrexate—breast cancer	5.53e-05	0.000426	CcSEcCtD
Didanosine—Headache—Thiotepa—breast cancer	5.5e-05	0.000424	CcSEcCtD
Didanosine—Arthralgia—Docetaxel—breast cancer	5.47e-05	0.000422	CcSEcCtD
Didanosine—Myalgia—Docetaxel—breast cancer	5.47e-05	0.000422	CcSEcCtD
Didanosine—Nausea—Vinorelbine—breast cancer	5.46e-05	0.000421	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	5.46e-05	0.000724	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP17A1—breast cancer	5.46e-05	0.000724	CbGpPWpGaD
Didanosine—Dyspepsia—Paclitaxel—breast cancer	5.45e-05	0.00042	CcSEcCtD
Didanosine—Asthenia—Irinotecan—breast cancer	5.44e-05	0.00042	CcSEcCtD
Didanosine—Asthenia—Mitoxantrone—breast cancer	5.44e-05	0.00042	CcSEcCtD
Didanosine—Neuropathy peripheral—Epirubicin—breast cancer	5.44e-05	0.000419	CcSEcCtD
Didanosine—PNP—Metabolism—ENO1—breast cancer	5.4e-05	0.000717	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS1—breast cancer	5.4e-05	0.000717	CbGpPWpGaD
Didanosine—Decreased appetite—Paclitaxel—breast cancer	5.38e-05	0.000415	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.37e-05	0.000713	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	5.35e-05	0.000711	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	5.35e-05	0.000711	CbGpPWpGaD
Didanosine—Hypersensitivity—Fluorouracil—breast cancer	5.35e-05	0.000413	CcSEcCtD
Didanosine—Dry mouth—Docetaxel—breast cancer	5.35e-05	0.000412	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—breast cancer	5.32e-05	0.00041	CcSEcCtD
Didanosine—Asthenia—Gemcitabine—breast cancer	5.3e-05	0.000409	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2D6—breast cancer	5.3e-05	0.000703	CbGpPWpGaD
Didanosine—Arthralgia—Capecitabine—breast cancer	5.3e-05	0.000408	CcSEcCtD
Didanosine—Myalgia—Capecitabine—breast cancer	5.3e-05	0.000408	CcSEcCtD
Didanosine—Pain—Paclitaxel—breast cancer	5.29e-05	0.000408	CcSEcCtD
Didanosine—Hepatobiliary disease—Epirubicin—breast cancer	5.24e-05	0.000404	CcSEcCtD
Didanosine—Anaphylactic shock—Docetaxel—breast cancer	5.24e-05	0.000404	CcSEcCtD
Didanosine—Discomfort—Capecitabine—breast cancer	5.23e-05	0.000403	CcSEcCtD
Didanosine—Pruritus—Gemcitabine—breast cancer	5.23e-05	0.000403	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—ALB—breast cancer	5.22e-05	0.000693	CbGpPWpGaD
Didanosine—Nausea—Thiotepa—breast cancer	5.22e-05	0.000402	CcSEcCtD
Didanosine—Infection—Docetaxel—breast cancer	5.21e-05	0.000402	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA2—breast cancer	5.2e-05	0.00069	CbGpPWpGaD
Didanosine—Hyperglycaemia—Doxorubicin—breast cancer	5.19e-05	0.0004	CcSEcCtD
Didanosine—Diarrhoea—Mitoxantrone—breast cancer	5.19e-05	0.0004	CcSEcCtD
Didanosine—Diarrhoea—Irinotecan—breast cancer	5.19e-05	0.0004	CcSEcCtD
Didanosine—Dry mouth—Capecitabine—breast cancer	5.18e-05	0.000399	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—breast cancer	5.17e-05	0.000399	CcSEcCtD
Didanosine—Pruritus—Fluorouracil—breast cancer	5.14e-05	0.000396	CcSEcCtD
Didanosine—Thrombocytopenia—Docetaxel—breast cancer	5.13e-05	0.000396	CcSEcCtD
Didanosine—Gastrointestinal pain—Paclitaxel—breast cancer	5.06e-05	0.00039	CcSEcCtD
Didanosine—Diarrhoea—Gemcitabine—breast cancer	5.06e-05	0.00039	CcSEcCtD
Didanosine—Infection—Capecitabine—breast cancer	5.04e-05	0.000389	CcSEcCtD
Didanosine—PNP—Metabolism—FASN—breast cancer	5.04e-05	0.000669	CbGpPWpGaD
Didanosine—Neuropathy peripheral—Doxorubicin—breast cancer	5.03e-05	0.000388	CcSEcCtD
Didanosine—PNP—Metabolism—BCHE—breast cancer	5.02e-05	0.000666	CbGpPWpGaD
Didanosine—Anorexia—Docetaxel—breast cancer	5e-05	0.000385	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—breast cancer	4.98e-05	0.000384	CcSEcCtD
Didanosine—Diarrhoea—Fluorouracil—breast cancer	4.97e-05	0.000383	CcSEcCtD
Didanosine—Thrombocytopenia—Capecitabine—breast cancer	4.97e-05	0.000383	CcSEcCtD
Didanosine—PNP—Metabolism—SLC5A5—breast cancer	4.96e-05	0.000658	CbGpPWpGaD
Didanosine—Hypoaesthesia—Epirubicin—breast cancer	4.95e-05	0.000382	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NCOA1—breast cancer	4.91e-05	0.000652	CbGpPWpGaD
Didanosine—Abdominal pain—Paclitaxel—breast cancer	4.89e-05	0.000377	CcSEcCtD
Didanosine—Body temperature increased—Paclitaxel—breast cancer	4.89e-05	0.000377	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—breast cancer	4.85e-05	0.000374	CcSEcCtD
Didanosine—Anorexia—Capecitabine—breast cancer	4.84e-05	0.000373	CcSEcCtD
Didanosine—Vomiting—Irinotecan—breast cancer	4.82e-05	0.000372	CcSEcCtD
Didanosine—Vomiting—Mitoxantrone—breast cancer	4.82e-05	0.000372	CcSEcCtD
Didanosine—PNP—Metabolism—NQO1—breast cancer	4.79e-05	0.000636	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC2A1—breast cancer	4.79e-05	0.000636	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PLG—breast cancer	4.79e-05	0.000636	CbGpPWpGaD
Didanosine—Agranulocytosis—Doxorubicin—breast cancer	4.79e-05	0.000369	CcSEcCtD
Didanosine—Rash—Mitoxantrone—breast cancer	4.78e-05	0.000369	CcSEcCtD
Didanosine—Rash—Irinotecan—breast cancer	4.78e-05	0.000369	CcSEcCtD
Didanosine—Dermatitis—Irinotecan—breast cancer	4.78e-05	0.000368	CcSEcCtD
Didanosine—Dermatitis—Mitoxantrone—breast cancer	4.78e-05	0.000368	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.78e-05	0.000368	CcSEcCtD
Didanosine—Chills—Methotrexate—breast cancer	4.77e-05	0.000368	CcSEcCtD
Didanosine—Headache—Mitoxantrone—breast cancer	4.75e-05	0.000366	CcSEcCtD
Didanosine—Headache—Irinotecan—breast cancer	4.75e-05	0.000366	CcSEcCtD
Didanosine—Paraesthesia—Docetaxel—breast cancer	4.71e-05	0.000363	CcSEcCtD
Didanosine—Alopecia—Methotrexate—breast cancer	4.7e-05	0.000362	CcSEcCtD
Didanosine—Vomiting—Gemcitabine—breast cancer	4.7e-05	0.000362	CcSEcCtD
Didanosine—PNP—Metabolism—CYP3A4—breast cancer	4.67e-05	0.00062	CbGpPWpGaD
Didanosine—Rash—Gemcitabine—breast cancer	4.66e-05	0.000359	CcSEcCtD
Didanosine—Dermatitis—Gemcitabine—breast cancer	4.65e-05	0.000359	CcSEcCtD
Didanosine—Headache—Gemcitabine—breast cancer	4.63e-05	0.000357	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.63e-05	0.000357	CcSEcCtD
Didanosine—Vomiting—Fluorouracil—breast cancer	4.62e-05	0.000356	CcSEcCtD
Didanosine—Dyspepsia—Docetaxel—breast cancer	4.62e-05	0.000356	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	4.61e-05	0.000612	CbGpPWpGaD
Didanosine—Hepatitis—Doxorubicin—breast cancer	4.61e-05	0.000355	CcSEcCtD
Didanosine—PNP—Metabolism—CYP1B1—breast cancer	4.59e-05	0.00061	CbGpPWpGaD
Didanosine—Hypoaesthesia—Doxorubicin—breast cancer	4.58e-05	0.000353	CcSEcCtD
Didanosine—Rash—Fluorouracil—breast cancer	4.58e-05	0.000353	CcSEcCtD
Didanosine—Dermatitis—Fluorouracil—breast cancer	4.58e-05	0.000353	CcSEcCtD
Didanosine—Paraesthesia—Capecitabine—breast cancer	4.56e-05	0.000351	CcSEcCtD
Didanosine—Decreased appetite—Docetaxel—breast cancer	4.56e-05	0.000351	CcSEcCtD
Didanosine—Hypersensitivity—Paclitaxel—breast cancer	4.56e-05	0.000351	CcSEcCtD
Didanosine—Headache—Fluorouracil—breast cancer	4.55e-05	0.000351	CcSEcCtD
Didanosine—Nausea—Mitoxantrone—breast cancer	4.51e-05	0.000347	CcSEcCtD
Didanosine—Nausea—Irinotecan—breast cancer	4.51e-05	0.000347	CcSEcCtD
Didanosine—PNP—Metabolism—HSP90AA1—breast cancer	4.5e-05	0.000598	CbGpPWpGaD
Didanosine—Pain—Docetaxel—breast cancer	4.48e-05	0.000346	CcSEcCtD
Didanosine—Dyspepsia—Capecitabine—breast cancer	4.47e-05	0.000344	CcSEcCtD
Didanosine—Chills—Epirubicin—breast cancer	4.47e-05	0.000344	CcSEcCtD
Didanosine—Asthenia—Paclitaxel—breast cancer	4.44e-05	0.000342	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—HMOX1—breast cancer	4.42e-05	0.000587	CbGpPWpGaD
Didanosine—Decreased appetite—Capecitabine—breast cancer	4.41e-05	0.00034	CcSEcCtD
Didanosine—Alopecia—Epirubicin—breast cancer	4.4e-05	0.000339	CcSEcCtD
Didanosine—Nausea—Gemcitabine—breast cancer	4.39e-05	0.000338	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA1—breast cancer	4.38e-05	0.000582	CbGpPWpGaD
Didanosine—Pruritus—Paclitaxel—breast cancer	4.38e-05	0.000337	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	4.38e-05	0.000581	CbGpPWpGaD
Didanosine—Pain—Capecitabine—breast cancer	4.34e-05	0.000335	CcSEcCtD
Didanosine—PNP—Metabolism—CYP19A1—breast cancer	4.32e-05	0.000573	CbGpPWpGaD
Didanosine—PNP—Metabolism—STK11—breast cancer	4.32e-05	0.000573	CbGpPWpGaD
Didanosine—Nausea—Fluorouracil—breast cancer	4.32e-05	0.000333	CcSEcCtD
Didanosine—Gastrointestinal pain—Docetaxel—breast cancer	4.29e-05	0.000331	CcSEcCtD
Didanosine—Anaemia—Methotrexate—breast cancer	4.28e-05	0.00033	CcSEcCtD
Didanosine—Flatulence—Epirubicin—breast cancer	4.27e-05	0.000329	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCB1—breast cancer	4.24e-05	0.000563	CbGpPWpGaD
Didanosine—Diarrhoea—Paclitaxel—breast cancer	4.23e-05	0.000326	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	4.23e-05	0.000561	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	4.22e-05	0.00056	CbGpPWpGaD
Didanosine—Malaise—Methotrexate—breast cancer	4.18e-05	0.000322	CcSEcCtD
Didanosine—Gastrointestinal pain—Capecitabine—breast cancer	4.15e-05	0.00032	CcSEcCtD
Didanosine—Body temperature increased—Docetaxel—breast cancer	4.15e-05	0.00032	CcSEcCtD
Didanosine—Abdominal pain—Docetaxel—breast cancer	4.15e-05	0.00032	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—breast cancer	4.14e-05	0.00032	CcSEcCtD
Didanosine—Chills—Doxorubicin—breast cancer	4.13e-05	0.000319	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—breast cancer	4.07e-05	0.000314	CcSEcCtD
Didanosine—PNP—Metabolism—COMT—breast cancer	4.01e-05	0.000533	CbGpPWpGaD
Didanosine—Body temperature increased—Capecitabine—breast cancer	4.01e-05	0.000309	CcSEcCtD
Didanosine—Abdominal pain—Capecitabine—breast cancer	4.01e-05	0.000309	CcSEcCtD
Didanosine—Anaemia—Epirubicin—breast cancer	4.01e-05	0.000309	CcSEcCtD
Didanosine—PNP—Metabolism—GSTP1—breast cancer	4e-05	0.00053	CbGpPWpGaD
Didanosine—Flatulence—Doxorubicin—breast cancer	3.95e-05	0.000305	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—breast cancer	3.94e-05	0.000304	CcSEcCtD
Didanosine—Myalgia—Methotrexate—breast cancer	3.94e-05	0.000304	CcSEcCtD
Didanosine—PNP—Metabolism—HMOX1—breast cancer	3.94e-05	0.000523	CbGpPWpGaD
Didanosine—Vomiting—Paclitaxel—breast cancer	3.93e-05	0.000303	CcSEcCtD
Didanosine—PNP—Metabolism—ITPR1—breast cancer	3.93e-05	0.000522	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	3.92e-05	0.00052	CbGpPWpGaD
Didanosine—Malaise—Epirubicin—breast cancer	3.91e-05	0.000301	CcSEcCtD
Didanosine—Rash—Paclitaxel—breast cancer	3.9e-05	0.000301	CcSEcCtD
Didanosine—Dermatitis—Paclitaxel—breast cancer	3.9e-05	0.0003	CcSEcCtD
Didanosine—Discomfort—Methotrexate—breast cancer	3.9e-05	0.0003	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—breast cancer	3.88e-05	0.000299	CcSEcCtD
Didanosine—Headache—Paclitaxel—breast cancer	3.88e-05	0.000299	CcSEcCtD
Didanosine—Hypersensitivity—Docetaxel—breast cancer	3.86e-05	0.000298	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ALB—breast cancer	3.83e-05	0.000508	CbGpPWpGaD
Didanosine—PNP—Metabolism—ABCB1—breast cancer	3.78e-05	0.000502	CbGpPWpGaD
Didanosine—Anaphylactic shock—Methotrexate—breast cancer	3.78e-05	0.000291	CcSEcCtD
Didanosine—Asthenia—Docetaxel—breast cancer	3.76e-05	0.00029	CcSEcCtD
Didanosine—Infection—Methotrexate—breast cancer	3.75e-05	0.000289	CcSEcCtD
Didanosine—Hypersensitivity—Capecitabine—breast cancer	3.74e-05	0.000288	CcSEcCtD
Didanosine—PNP—Metabolism—TYMS—breast cancer	3.71e-05	0.000493	CbGpPWpGaD
Didanosine—Pruritus—Docetaxel—breast cancer	3.71e-05	0.000286	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—breast cancer	3.71e-05	0.000286	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—breast cancer	3.7e-05	0.000285	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—breast cancer	3.69e-05	0.000284	CcSEcCtD
Didanosine—Myalgia—Epirubicin—breast cancer	3.69e-05	0.000284	CcSEcCtD
Didanosine—Nausea—Paclitaxel—breast cancer	3.67e-05	0.000283	CcSEcCtD
Didanosine—PNP—Metabolism—GSTM1—breast cancer	3.67e-05	0.000487	CbGpPWpGaD
Didanosine—PNP—Metabolism—PLA2G4A—breast cancer	3.67e-05	0.000487	CbGpPWpGaD
Didanosine—PNP—Metabolism—NCOR1—breast cancer	3.67e-05	0.000487	CbGpPWpGaD
Didanosine—Discomfort—Epirubicin—breast cancer	3.65e-05	0.000281	CcSEcCtD
Didanosine—Asthenia—Capecitabine—breast cancer	3.64e-05	0.000281	CcSEcCtD
Didanosine—Malaise—Doxorubicin—breast cancer	3.62e-05	0.000279	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—breast cancer	3.61e-05	0.000278	CcSEcCtD
Didanosine—Anorexia—Methotrexate—breast cancer	3.6e-05	0.000278	CcSEcCtD
Didanosine—Pruritus—Capecitabine—breast cancer	3.59e-05	0.000277	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—breast cancer	3.59e-05	0.000277	CcSEcCtD
Didanosine—Diarrhoea—Docetaxel—breast cancer	3.59e-05	0.000277	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—breast cancer	3.54e-05	0.000273	CcSEcCtD
Didanosine—PNP—Metabolism—GPX1—breast cancer	3.52e-05	0.000467	CbGpPWpGaD
Didanosine—Infection—Epirubicin—breast cancer	3.51e-05	0.000271	CcSEcCtD
Didanosine—PNP—Metabolism—CYP1A1—breast cancer	3.48e-05	0.000462	CbGpPWpGaD
Didanosine—Diarrhoea—Capecitabine—breast cancer	3.47e-05	0.000268	CcSEcCtD
Didanosine—Thrombocytopenia—Epirubicin—breast cancer	3.46e-05	0.000267	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RAF1—breast cancer	3.46e-05	0.00046	CbGpPWpGaD
Didanosine—PNP—Metabolism—ERCC2—breast cancer	3.45e-05	0.000458	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.44e-05	0.000265	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—breast cancer	3.41e-05	0.000263	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—breast cancer	3.41e-05	0.000263	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—breast cancer	3.39e-05	0.000262	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—breast cancer	3.37e-05	0.00026	CcSEcCtD
Didanosine—Anorexia—Epirubicin—breast cancer	3.37e-05	0.00026	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—breast cancer	3.34e-05	0.000257	CcSEcCtD
Didanosine—Vomiting—Docetaxel—breast cancer	3.33e-05	0.000257	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	3.33e-05	0.000442	CbGpPWpGaD
Didanosine—Dyspepsia—Methotrexate—breast cancer	3.33e-05	0.000256	CcSEcCtD
Didanosine—Rash—Docetaxel—breast cancer	3.31e-05	0.000255	CcSEcCtD
Didanosine—Dermatitis—Docetaxel—breast cancer	3.3e-05	0.000255	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—breast cancer	3.29e-05	0.000253	CcSEcCtD
Didanosine—Headache—Docetaxel—breast cancer	3.28e-05	0.000253	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—breast cancer	3.27e-05	0.000252	CcSEcCtD
Didanosine—Infection—Doxorubicin—breast cancer	3.25e-05	0.000251	CcSEcCtD
Didanosine—PNP—Metabolism—MTHFR—breast cancer	3.24e-05	0.000431	CbGpPWpGaD
Didanosine—Pain—Methotrexate—breast cancer	3.23e-05	0.000249	CcSEcCtD
Didanosine—Vomiting—Capecitabine—breast cancer	3.23e-05	0.000249	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.22e-05	0.000248	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—breast cancer	3.2e-05	0.000247	CcSEcCtD
Didanosine—Rash—Capecitabine—breast cancer	3.2e-05	0.000247	CcSEcCtD
Didanosine—Dermatitis—Capecitabine—breast cancer	3.2e-05	0.000247	CcSEcCtD
Didanosine—Headache—Capecitabine—breast cancer	3.18e-05	0.000245	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—breast cancer	3.18e-05	0.000245	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—breast cancer	3.12e-05	0.00024	CcSEcCtD
Didanosine—Nausea—Docetaxel—breast cancer	3.11e-05	0.00024	CcSEcCtD
Didanosine—Dyspepsia—Epirubicin—breast cancer	3.11e-05	0.00024	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—breast cancer	3.09e-05	0.000238	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—breast cancer	3.07e-05	0.000237	CcSEcCtD
Didanosine—Pain—Epirubicin—breast cancer	3.02e-05	0.000233	CcSEcCtD
Didanosine—Nausea—Capecitabine—breast cancer	3.02e-05	0.000232	CcSEcCtD
Didanosine—PNP—Metabolism—CAV1—breast cancer	2.99e-05	0.000397	CbGpPWpGaD
Didanosine—Body temperature increased—Methotrexate—breast cancer	2.99e-05	0.00023	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—breast cancer	2.99e-05	0.00023	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.98e-05	0.00023	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—breast cancer	2.94e-05	0.000227	CcSEcCtD
Didanosine—Gastrointestinal pain—Epirubicin—breast cancer	2.89e-05	0.000223	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—breast cancer	2.88e-05	0.000222	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—breast cancer	2.84e-05	0.000219	CcSEcCtD
Didanosine—Pain—Doxorubicin—breast cancer	2.8e-05	0.000216	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—breast cancer	2.8e-05	0.000216	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—breast cancer	2.8e-05	0.000216	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—breast cancer	2.78e-05	0.000215	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	2.77e-05	0.000368	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CG—breast cancer	2.73e-05	0.000362	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	2.72e-05	0.000361	CbGpPWpGaD
Didanosine—Asthenia—Methotrexate—breast cancer	2.71e-05	0.000209	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—breast cancer	2.68e-05	0.000206	CcSEcCtD
Didanosine—Pruritus—Methotrexate—breast cancer	2.67e-05	0.000206	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ALB—breast cancer	2.65e-05	0.000352	CbGpPWpGaD
Didanosine—Hypersensitivity—Epirubicin—breast cancer	2.61e-05	0.000201	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—breast cancer	2.59e-05	0.000199	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—breast cancer	2.59e-05	0.000199	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—breast cancer	2.59e-05	0.000199	CcSEcCtD
Didanosine—Asthenia—Epirubicin—breast cancer	2.54e-05	0.000196	CcSEcCtD
Didanosine—Pruritus—Epirubicin—breast cancer	2.5e-05	0.000193	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	2.42e-05	0.000321	CbGpPWpGaD
Didanosine—Diarrhoea—Epirubicin—breast cancer	2.42e-05	0.000187	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—breast cancer	2.41e-05	0.000186	CcSEcCtD
Didanosine—Vomiting—Methotrexate—breast cancer	2.4e-05	0.000185	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RAF1—breast cancer	2.4e-05	0.000319	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CD—breast cancer	2.4e-05	0.000318	CbGpPWpGaD
Didanosine—Rash—Methotrexate—breast cancer	2.38e-05	0.000184	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—breast cancer	2.38e-05	0.000184	CcSEcCtD
Didanosine—Headache—Methotrexate—breast cancer	2.37e-05	0.000182	CcSEcCtD
Didanosine—PNP—Metabolism—ALB—breast cancer	2.37e-05	0.000314	CbGpPWpGaD
Didanosine—Asthenia—Doxorubicin—breast cancer	2.35e-05	0.000181	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	2.33e-05	0.000309	CbGpPWpGaD
Didanosine—Pruritus—Doxorubicin—breast cancer	2.32e-05	0.000178	CcSEcCtD
Didanosine—PNP—Metabolism—NOS3—breast cancer	2.26e-05	0.0003	CbGpPWpGaD
Didanosine—Vomiting—Epirubicin—breast cancer	2.25e-05	0.000173	CcSEcCtD
Didanosine—Nausea—Methotrexate—breast cancer	2.24e-05	0.000173	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—breast cancer	2.24e-05	0.000173	CcSEcCtD
Didanosine—Rash—Epirubicin—breast cancer	2.23e-05	0.000172	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—breast cancer	2.23e-05	0.000172	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	2.22e-05	0.000295	CbGpPWpGaD
Didanosine—Headache—Epirubicin—breast cancer	2.22e-05	0.000171	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	2.15e-05	0.000285	CbGpPWpGaD
Didanosine—Nausea—Epirubicin—breast cancer	2.1e-05	0.000162	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3CB—breast cancer	2.09e-05	0.000277	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	2.09e-05	0.000277	CbGpPWpGaD
Didanosine—Vomiting—Doxorubicin—breast cancer	2.08e-05	0.00016	CcSEcCtD
Didanosine—PNP—Metabolism—PTGS2—breast cancer	2.07e-05	0.000275	CbGpPWpGaD
Didanosine—Rash—Doxorubicin—breast cancer	2.06e-05	0.000159	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—breast cancer	2.06e-05	0.000159	CcSEcCtD
Didanosine—Headache—Doxorubicin—breast cancer	2.05e-05	0.000158	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	1.96e-05	0.000261	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—breast cancer	1.94e-05	0.00015	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	1.91e-05	0.000254	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTEN—breast cancer	1.81e-05	0.00024	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	1.77e-05	0.000234	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	1.7e-05	0.000225	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CA—breast cancer	1.27e-05	0.000169	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	1.06e-05	0.000141	CbGpPWpGaD
Didanosine—PNP—Metabolism—AKT1—breast cancer	1.04e-05	0.000138	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	9.59e-06	0.000127	CbGpPWpGaD
